As of Apr 27
| -0.295 / -2.85%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 29.00 and a low estimate of 17.00. The median estimate represents a +98.91% increase from the last price of 10.06.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.